EUVIMEDEUVIMED entdecken
Crossref

Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy: Narsoplimab Enters the Arena

Meera Sridharan

The Hematologist · 01.05.2026 · 23 (3)

DOI: 10.1182/hem.v23.3.202633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Hematologist, online erschienen am 17.04.2026. Verfasst von Meera Sridharan. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sridharan, M. (2026). Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy: Narsoplimab Enters the Arena. The Hematologist, 23(3). https://doi.org/10.1182/hem.v23.3.202633

Vancouver

Sridharan M. Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy: Narsoplimab Enters the Arena. The Hematologist. 2026;23(3). doi:10.1182/hem.v23.3.202633

BibTeX
@article{Sridharan2026,
  author = {Sridharan, Meera},
  title = {Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy: Narsoplimab Enters the Arena},
  journal = {The Hematologist},
  year = {2026},
  volume = {23},
  number = {3},
  doi = {10.1182/hem.v23.3.202633}
}
Kostenlos starten →